Other
Post Operative Pain
22
Pipeline Programs↗
78
Active Trials↗
26
Companies Involved↗
Post Operative Pain is an emerging landscape with 22 programs across 26 companies. The most active players are Pacira Pharmaceuticals, Inc, TLC Biopharmaceuticals, Inc., Shanghai Huilun Pharmaceutical Co., Ltd.. 5 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical12
Phase 2
No programs
Phase 33
Analysis
Trial Status
398
clinical trials
Completed216 · 54%
Unknown status77 · 19%
Recruiting50 · 13%
Not yet recruiting20 · 5%
Terminated16 · 4%
Withdrawn10 · 3%
Other9 · 2%
Clinical Trials
Trial Activity
398 trials
Dextromethorphan for Treatment of Postoperative Pain
Recruiting·—·N/A·NCT05278494·160 enrolled
Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain
Recruiting·—·N/A·NCT05282251·60 enrolled
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
Recruiting·—·N/A·NCT06420388·400 enrolled
Melatonin on Post Operative Pain After CS
Recruiting·—·N/A·NCT07380568·60 enrolled
The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain
Recruiting·—·N/A·NCT06298383·120 enrolled
Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension
Recruiting·—·N/A·NCT07440576·58 enrolled
Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy
Recruiting·—·Phase 4·NCT06406010·90 enrolled
Comparison of ESP and QL Blocks for Postoperative Pain in Pediatric Appendectomy (ESP-QLB)
Recruiting·—·N/A·NCT07301528·60 enrolled
Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA
Recruiting·—·N/A·NCT06880471·51 enrolled
Page 1 of 27
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)